VFA
TWST icon

Virtus Fund Advisers’s Twist Bioscience TWST Stock Holding History

Virtus Fund Advisers’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$83.6K Buy
1,798
+62
+4% +$2.8K 0.26% 32
2024
Q3 		$78.4K Hold
1,736
– – 0.32% 37
2024
Q2 		$85.5K Buy
1,736
+107
+7% +$4.36K 0.34% 31
2024
Q1 		$55.9K Hold
1,629
– – 0.2% 58
2023
Q4 		$60K Sell
1,629
-260
-14% -$6.01K 0.37% 42
2023
Q3 		$38.3K Hold
1,889
– – 0.27% 62
2023
Q2 		$38.6K Buy
+1,889
New +$28.3K 0.27% 63

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtus Fund Advisers's TWST Position: Q4 2024 in Review

Virtus Fund Advisers increased its Twist Bioscience (TWST) stake by 3.6% in Q4 2024, buying an estimated $2.8K and bringing the position to 1,798 shares worth $83.6K. The position accounts for 0.26% of the portfolio, ranked #32.

Virtus Fund Advisers first reported a position in TWST in Q2 2023 and has held it in 7 quarters since. The position peaked at $85.5K in Q2 2024. 247 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Virtus Fund Advisers held 1,798 shares of Twist Bioscience worth $83.6K as of Q4 2024.
  • Virtus Fund Advisers bought 62 Twist Bioscience shares in Q4 2024, an estimated $2.8K.
  • Twist Bioscience made up 0.26% of Virtus Fund Advisers's portfolio in Q4 2024, its #32 holding.
  • Virtus Fund Advisers first reported a position in Twist Bioscience in Q2 2023 and has held it in 7 quarters since.
  • Virtus Fund Advisers's Twist Bioscience position peaked at $85.5K in Q2 2024.
  • 247 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.